GGO | Pub date | Age | BMI | Habitus | Gender | Medical condit. | Infectious disease | Vaping/ month | ‘Cannabis’ | Tox. screen | PSP/SSP | ‘Coughing’ | Bilateral | Latency/ days | Ventilation | ECMO/ days | Re.pneu/ fistula | Surgery |
Yes | 20196 | 35 | M | None | None | 48 | Yes | n.r. | SSP | Yes | 8 | No | No | Pleurectomy, blebectomy | ||||
Yes | 201920 | 40 | M | IV drugs | Hep B | n.r. | n.r. | SSP | Yes | Yes | Yes | 42 | No | Chest tube | ||||
Yes | 202013 | 34 | M | None | None | n.r. | n.r. | SSP | Yes | >4 | No | No | Chest tube | |||||
Yes | 202023 | 23 | F | None | None | 1 | Yes | Yes | SSP | No | >18 | Yes | No | |||||
Yes | 202019 | 16 | Poor nutrition | F | Chronic abdo pain | None | 12 | Yes | Yes | SSP | No | Yes | 30 | Yes | Chest tube | |||
Yes | 202021 | 19 | M | None | None | 1 | Yes | n.r. | SSP | No | Yes | No | No | Chest tube | ||||
Yes | 202018 | 35 | M | Type 1 DM | None | 1 | Yes | Yes | SSP | No | Yes | No | No | |||||
Yes | 202014 | 17 | F | Bipolar disorder | None | Yes | n.r. | SSP | Yes | Yes | Yes | No | ||||||
Yes | 202016 | 35 | M | None | None | 2 | Yes | Yes | SSP | Yes | Yes | Yes | No | Pleurodesis | ||||
Yes | 202022 | 19 | M | Asthma | None | Yes | Yes | SSP | Yes | Yes | 8 | Yes | 29 | Yes | Chest tube | |||
Yes | 202024 | 25 | M | None | None | Yes | Yes | SSP | No | Yes | Yes | Yes | Yes | Yes | Chest tube | |||
No | 201725 | 21 | M | None | None | 7 | n.r. | n.r. | SSP | Yes | No | No | Pleurectomy, pleurodesis | |||||
No | 20195 | 18 | 16.9 | Underweight | M | None | None | 18 | Yes | n.r. | SSP | No | No | Yes | ||||
No | 201915 | 15 | 19 | M | None | None | n.r. | n.r. | PSP | No | No | Yes | Pleurodesis, no blebs | |||||
No | 201915 | 16 | 18.6 | M | None | None | No | n.r. | SSP | No | No | Yes | Pleurectomy, blebectomy | |||||
No | 202017 | 25 | M | None | None | 12 | Yes | Yes | SSP | No | No | No | ||||||
No | 202013 | 21 | M | None | None | 36 | n.r. | n.r. | PSP | Yes | No | No | Chest tube | |||||
No | 2021* | 34 | 23.6 | Muscular build | M | None | None | 36 | No | Yes | SSP | Yes | No | No | Pleurectomy, blebectomy |
Cases in two groups: patients with ground glass opacities (GGO) on CT scan or any other major structural lung parenchyma changes; BMI is body mass index; ‘cannabis’ relates to any kind of cannabinoids used for vaping as mentioned in reports; tox. screen relates to any kind of toxicology screen used to validate the use of cannabinoids; PSP/SSP relates to primary and secondary spontaneous pneumothorax being reclassified by authors if any signs of pre-existing disease like GGO on X-ray or CT thorax or blebs as a sign of emphysema in chronic smokers/vapers were evident from the reports; ‘coughing’ relates to any kind of reporting a strain on the thorax including a cough, heavy lifting or else; bilateral, that is, bilateral pneumothoraces; latency is latency in days from evidence of lung disease (respiratory distress) until occurrence of secondary spontaneous pneumothorax; ventilation indicates whether patients were put on a respirator; ECMO/days reports the days the patient needed extracorporeal membrane oxygenation; re.pneu/fistula reports whether patients developed recurrent pneumothorax or a bronchial fistula after first occurrence of a pneumothorax; surgery reports whether patients had any type of surgical intervention; n.r. denotes not reported.
*Authors’ case.
EVALI, E-cigarette or Vaping Product Use-Associated Lung Injury; IV, intravenous.